Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 9 clinical trials
Avatrombopag in Primary Immune Thrombocytopenia (ITP) in Adults

This single-center study aims to study the efficacy and safety of avatrombopag in Chinese adult ITP patients. This study will be conducted in adult ITP patients who had not responded to

  • 0 views
  • 28 May, 2021
  • 1 location
Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for 6 Months

A Phase 3b Study to Evaluate the Efficacy and Safety of Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects with Immune Thrombocytopenia for 6 Months

thrombocytopenia
avatrombopag
  • 13 views
  • 14 Aug, 2021
  • 37 locations
Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

To evaluate the efficacy and safety of Avatrombopag in patients with thrombocytopenia induced by targeted therapy and immunotherapy combination treatment, and provide evidence-based medication

cancer
avatrombopag
  • 0 views
  • 30 May, 2021
  • 1 location
Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies

This prospective, open-label, single-center, one-arm clinical trial aims at evaluating the efficacy and safety of avatrombopag in Chinese adult Immune Thrombocytopenia (ITP) patients with

platelet count
avatrombopag
glucocorticoids
evans syndrome
recombinant human thrombopoietin
  • 0 views
  • 12 Aug, 2021
  • 1 location
Avatrombopag in Patients With End-stage Liver Disease and Thrombocytopenia

Avatrombopag in Patients with End-stage Liver Disease and Thrombocytopenia.

liver disease
cirrhosis
platelet count
avatrombopag
  • 0 views
  • 16 Jun, 2021
  • 1 location
Avatrombopag for the Treatment of Thrombocytopenia After Donor Hematopoietic Stem Cell Transplant

This phase II trial studies the side effects and how well avatrombopag works for the treatment of thrombocytopenia after donor hematopoietic stem cell transplant. Thrombocytopenia is defined as

thrombocytopenia
platelet count
hematopoietic stem cell transplant
  • 0 views
  • 25 Jan, 2021
  • 1 location
Efficacy of Avatrombopag in Thrombocytopenic Patients With Chronic Liver Disease Undergoing an Elective Procedure

In this study, investigators aimed to evaluate the efficacy of Avatrombopag in thrombocytopenic patients with chronic liver disease undergoing an elective invasive procedure through a

  • 0 views
  • 22 Jun, 2021
  • 1 location
Open-label Study Measuring Safety and Treatment Satisfaction in Adult Subjects With Chronic Immune Thrombocytopenia (ITP) After Switching to Avatrombopag From Eltrombopag or Romiplostim

Evaluate the safety and tolerability of avatrombopag given for 90 days after stopping treatment with eltrombopag or romiplostim.

avatrombopag
eltrombopag
thrombocytopenia
romiplostim
  • 0 views
  • 17 Sep, 2021
  • 5 locations
Avatrombopag in the Treatment of Primary Immune Thrombocytopenia(ITP)

The project was undertaking by Qilu Hospital of Shandong University and other well-known hospitals in China. Aims at evaluating effectiveness and safety of avatrombopag in the treatment of

  • 0 views
  • 10 Jul, 2021
  • 1 location